 |
인쇄하기
취소
|
LG launches home-grown diabetes treatment
LG Life Sciences (LGLS) said Monday that it has launched Gemiglo (gemigliptin) here, which is effective on type-2 diabetes patients, who have a high blood sugar level though their insulin secretion is working.
Gemiglo, the main substance of which is gemigliptin, is the 19th new drug developed by a domestic pharmaceutical company and fifth new diabetes treatment in the world. LGLS spent a tot...
Gemiglo, the main substance of which is gemigliptin, is the 19th new drug developed by a domestic pharmaceutical company and fifth new diabetes treatment in the world. LGLS spent a tot...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.